← All organizations
Highest phase reached
Phase 2
First clinical trial
Sep 15, 2022Last known activity
Jul 1, 2024
Timeline
2010s
- Jan 1, 2016
Exeliom Biosciences— Founded
Drugs by trial phase (1 distinct, 3 trials)
Phase 2 (1 own, 0 via acquisition)
Recent trials (4)
- NCT06448572CollaboratorPhase 1/Phase 2Jul 1, 2024
- NCT06306014CollaboratorPhase 1/Phase 2May 7, 2024
- NCT05542355Lead sponsorPhase 1Sep 15, 2022
- NCT05542355Study directorPhase 1Sep 15, 2022
Details
- Founded
- Dijon, FR Jan 1, 2016
- Last known activity
- Jul 1, 2024